Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Rheumatoid Arthritis

  Free Subscription


Articles published in Z Rheumatol

Retrieve available abstracts of 52 articles:
HTML format
Text format



Single Articles


    September 2017
  1. KOTHE R
    [Low back pain in rheumatoid arthritis].
    Z Rheumatol. 2017 Sep 5. doi: 10.1007/s00393-017-0363.
    PubMed     Text format     Abstract available


    August 2017
  2. KOTTER I, Stubiger N, Deuter C
    [Ocular involvement in rheumatoid arthritis, connective tissue diseases and vasculitis].
    Z Rheumatol. 2017 Aug 31. doi: 10.1007/s00393-017-0372.
    PubMed     Text format     Abstract available


  3. STROBEL S, Rossol M
    [Monocyte subpopulations in patients with rheumatoid arthritis].
    Z Rheumatol. 2017 Aug 3. doi: 10.1007/s00393-017-0352.
    PubMed     Text format    


    May 2017
  4. BAE SC, Lee YH
    Association between anti-Porphyromonas gingivalis antibody, anti-citrullinated protein antibodies, and rheumatoid arthritis : A meta-analysis.
    Z Rheumatol. 2017 May 29. doi: 10.1007/s00393-017-0328.
    PubMed     Text format     Abstract available


    April 2017
  5. KEYSSER G
    [Success for a new generation of disease-modifying antirheumatic drugs : The Janus kinase inhibitor baricitinib in rheumatoid arthritis].
    Z Rheumatol. 2017 Apr 26. doi: 10.1007/s00393-017-0307.
    PubMed     Text format    


  6. ALBRECHT K, Richter A, Meissner Y, Huscher D, et al
    [How frequent are poor prognostic markers in rheumatoid arthritis? : An estimate based on three epidemiologic cohorts].
    Z Rheumatol. 2017 Apr 20. doi: 10.1007/s00393-017-0306.
    PubMed     Text format     Abstract available


    March 2017
  7. ALBRECHT K, Luque Ramos A, Callhoff J, Hoffmann F, et al
    [Outpatient care and disease burden of rheumatoid arthritis : Results of a linkage of claims data and a survey of insured persons].
    Z Rheumatol. 2017 Mar 21. doi: 10.1007/s00393-017-0294.
    PubMed     Text format     Abstract available


  8. BAE SC, Lee YH
    Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis : A Bayesian network meta-analysis of randomized controlled trials.
    Z Rheumatol. 2017 Mar 21. doi: 10.1007/s00393-017-0292.
    PubMed     Text format     Abstract available


    January 2017
  9. SCHNEIDER M
    [New options for the practice : Update S1/S2 guidelines on rheumatoid arthritis?]
    Z Rheumatol. 2017 Jan 19. doi: 10.1007/s00393-016-0261.
    PubMed     Text format     Abstract available


  10. LEE YH, Bae SC
    Comparative efficacy and safety of baricitinib 2 mg and 4 mg in patients with active rheumatoid arthritis : A Bayesian network meta-analysis of randomized controlled trials.
    Z Rheumatol. 2017 Jan 17. doi: 10.1007/s00393-016-0254.
    PubMed     Text format     Abstract available


  11. WEBER S, Pongratz G, Schneider M, Brinks R, et al
    Need for improvements in reported cost effectiveness of adalimumab in rheumatoid arthritis.
    Z Rheumatol. 2017 Jan 13. doi: 10.1007/s00393-016-0255.
    PubMed     Text format    


  12. GISSEL C, Gotz G, Repp H
    Reply to: Need for improvements in reported cost-effectiveness of adalimumab in rheumatoid arthritis.
    Z Rheumatol. 2017 Jan 13. doi: 10.1007/s00393-016-0256.
    PubMed     Text format    


  13. ALETAHA D, Kerschbaumer A
    [Rheumatoid arthritis].
    Z Rheumatol. 2017 Jan 5. doi: 10.1007/s00393-016-0251.
    PubMed     Text format     Abstract available


    December 2016
  14. BES C, Gurel S, Bugdayci G, Dikbas O, et al
    Atherosclerosis assessment and rheumatoid arthritis.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  15. FADDA SM, Bassyouni IH, Khalifa RH, Elsaid NY, et al
    Pleiotrophin, the angiogenic and mitogenic growth factor: levels in serum and synovial fluid in rheumatoid arthritis and osteoarthritis : And correlation with clinical, laboratory and radiological indices.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  16. WANG X, Yan X, Wang F, Ge F, et al
    Role of methotrexate chronotherapy in collagen-induced rheumatoid arthritis in rats.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  17. LEE YH, Bae SC
    Correlation between circulating VEGF levels and disease activity in rheumatoid arthritis: a meta-analysis.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  18. LEE YH, Bae SC
    Association between shortened telomere length and rheumatoid arthritis : A meta-analysis.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  19. ZENGIN O, Onder ME, Kalem A, Bilici M, et al
    New inflammatory markers in early rheumatoid arthritis.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  20. YANG XK, Li P, Zhang C, Leng RX, et al
    Association between IRAK1 rs3027898 and miRNA-499 rs3746444 polymorphisms and rheumatoid arthritis : A case control study and meta-analysis.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  21. PATTLOCH D, Richter A, Manger B, Dockhorn R, et al
    [The first biologic for rheumatoid arthritis: factors influencing the therapeutic decision].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  22. LEE YH, Bae SC
    Associations between eNOS polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  23. HARRE U, Schett G
    [Association between bone catabolism and anti-citrullinated protein antibodies in rheumatoid arthritis].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  24. KLEIN K, Gay RE, Gay S
    [Synovial fibroblasts : Main players in rheumatoid arthritis].
    Z Rheumatol. 2016.
    PubMed     Text format    


  25. ALBRECHT K, Huscher D, Eidner T, Kleinert S, et al
    [Medical treatment of rheumatoid arthritis in 2014 : Current data from the German Collaborative Arthritis Centers].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  26. LEE YH, Bae SC
    Efficacy and safety of methotrexate plus certolizumab pegol or placebo in active rheumatoid arthritis : Meta-analysis of randomized controlled trials.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  27. LEE YH, Bae SC
    Diagnostic accuracy of anti-Sa and anti-RA33 antibodies in rheumatoid arthritis: a meta-analysis.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  28. BRAUN J, Krause A, Aringer M, Burmester G, et al
    [Standards of care for people with rheumatoid arthritis in Europe : Translation and comments of the eumusc.net recommendations supported by EULAR performed by a national task force of the professional organisations DGRh and VRA supported by "Deutsche
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  29. HENSE S, Luque Ramos A, Callhoff J, Albrecht K, et al
    [Prevalence of rheumatoid arthritis in Germany based on health insurance data : Regional differences and first results of the PROCLAIR study].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  30. GISSEL C, Gotz G, Repp H
    Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  31. BRAUN J, Bessler F, Lakomek HJ, Rudwaleit M, et al
    [International quality indicators in rheumatology : Suggestions for rheumatoid arthritis].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  32. BRAUN J, Schneider M, Lakomek HJ
    [Cornerstones of quality assurance in medicine in Germany. Important impulse for the situation in treatment of rheumatism].
    Z Rheumatol. 2016;75:203-12.
    PubMed     Text format     Abstract available


    February 2016
  33. SPRINGORUM HR, Winkler S, Maderbacher G, Gotz J, et al
    [Operative therapy for rheumatoid arthritis of the hand].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  34. RUBBERT-ROTH A, Zander T, Kneitz C, Baerwald C, et al
    [Lung cancer and rheumatoid arthritis : An interdisciplinary challenge].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  35. BURKHARDT H, Weisenseel P, Radtke MA, Kruger K, et al
    [Malignancies of the skin and immunomodulatory antirheumatic therapy].
    Z Rheumatol. 2016;75:32-40.
    PubMed     Text format     Abstract available


  36. TONY HP
    [Rheumatism and cancer].
    Z Rheumatol. 2016;75:11-2.
    PubMed     Text format    


    January 2016
  37. LEE YH, Bae SC
    Circulating leptin level in rheumatoid arthritis and its correlation with disease activity: a meta-analysis.
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  38. WALDNER MJ, Strangfeld A, Aringer M
    [Influence of therapy on risk of cancer in rheumatoid arthritis : Pathophysiological principles].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  39. KLEINERT S, Waldner M, Wendler J, Kunzmann V, et al
    [Disease-modifying antirheumatic drugs in rheumatoid arthritis patients with a history of colorectal cancer].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  40. BOEGEMANN M, Alten R, Aringer M, Zastrow S, et al
    [Genitourinary malignancies and rheumatoid arthritis].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


  41. SCHMALZING M, Strangfeld A, Tony HP
    [Medication treatment of rheumatoid arthritis with a history of malignancy : Epidemiological data].
    Z Rheumatol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  42. EL DEFRAWY AO, Gheita TA, Raslan HM, El Ansary MM, et al
    Serum and synovial cartilage oligomeric matrix protein levels in early and established rheumatoid arthritis.
    Z Rheumatol. 2015.
    PubMed     Text format     Abstract available


  43. ALBRECHT K, Callhoff J, Edelmann E, Schett G, et al
    [Clinical remission in rheumatoid arthritis : Data from the early arthritis cohort study CAPEA].
    Z Rheumatol. 2015.
    PubMed     Text format     Abstract available


    June 2015
  44. RUBBERT-ROTH A
    [Switching within the active ingredient group or changing the mechanism of action. Data situation by failure of the first line biologic].
    Z Rheumatol. 2015;74:406-13.
    PubMed     Text format     Abstract available


    May 2015

  45. [How does periodontitis have an impact on RA].
    Z Rheumatol. 2015;74:283.
    PubMed     Text format    



  46. [Risk of infection among biologics].
    Z Rheumatol. 2015;74:282.
    PubMed     Text format    


  47. LEE YH, Bae SC, Kim JH, Seo YH, et al
    Meta-analysis of SLC22A4 and RUNX1 polymorphisms : Associations with rheumatoid arthritis susceptibility.
    Z Rheumatol. 2015;74:351-8.
    PubMed     Text format     Abstract available


    March 2015
  48. STRANGFELD A, Richter A
    [How do register data support clinical decision-making?].
    Z Rheumatol. 2015;74:119-24.
    PubMed     Text format     Abstract available


    February 2015
  49. KALDEN JR
    [Pathogenic cells of rheumatic inflammation as the target of modern therapies].
    Z Rheumatol. 2015;74:8-13.
    PubMed     Text format     Abstract available


  50. HIEPE F, Alexander T, Voll RE
    [Plasma cells].
    Z Rheumatol. 2015;74:20-5.
    PubMed     Text format     Abstract available


  51. LEIPE J, Chang HD
    [Effector T cells].
    Z Rheumatol. 2015;74:14-9.
    PubMed     Text format     Abstract available


  52. LEIPE J
    [Interleukin-22 - friend or foe?].
    Z Rheumatol. 2015;74:51-3.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: